2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00876772 (ClinicalTrials.gov)	March 2011	6/4/2009	Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)	Randomized, Placebo-controlled Parallel Group Study for the Evaluation of an Oral Dose of 10mg Olanz ...	Amyotrophic Lateral Sclerosis (ALS)	Drug: Olanzapine	Charite University, Berlin, Germany	NULL	Recruiting	18 Years	80 Years	Both	40	Phase 2/Phase 3	Germany
2	EUCTR2007-003775-39-DE (EUCTR)	29/10/2008	09/09/2008	Randomised, placebo-controlled parallel-group trial to evaluate an oral dose of 10 mg Olanzapincombi ...	Randomised, placebo-controlled parallel-group trial to evaluate an oral dose of 10 mg Olanzapincombi ...	patients with amyotrophic lateral sclerosis	Trade Name: Zyprexa INN or Proposed INN: OLANZAPINE	Charité – Universitätsmedizin Berlin	NULL	Not Recruiting			Female: yes Male: yes			Germany

First Previous1Next Last